Chronic Rhinosinusitis and Endoscopic Sinus Surgery
Chronic Rhinosinusitis affects 1 in 8 adults in the US, causing a range of debilitating symptoms that significantly impact their quality of life. These symptoms include nasal congestion, headaches, facial pain, sinus pressure, nasal discharge, loss of smell or taste, and sleep deprivation.
Endoscopic Sinus Surgery (ESS) is the preferred treatment for chronic sinusitis. ESS aims to eliminate factors contributing to sinus inflammation and restore ventilation and drainage of the paranasal sinuses. This procedure involves removing diseased sinus tissue, and may also involve the removal of nasal polyps that obstruct mucus and airflow.
Success Factors for ESS
Three key factors determine the long-term success of ESS:
- Maintenance of sinus ostium patency to prevent stenosis: the incidence of ostial stenosis following ESS has been estimated to be approximately 25%, with the frontal sinus having the highest rate of stenosis at rates reported of up to 60%.
- Prevention of scarring and adhesion formation: scarring and adhesion formation are reported as the two main causes of surgical failure, estimated to occur in between 10 to 30% of patients.
- Patient comfort and compliance to minimize post-operative complications: removable packing has long been the traditional method of preventing adhesion formation and keeping the sinuses open following ESS. However, it is rated by patients as the most unpleasant and painful aspect of the ESS experience, and is associated with significant mucosal trauma once the pack is removed.
Chitogel’s Unique Benefits
Chitogel is a hydrogel sinus dressing applied after ESS to address traditional surgical challenges and improve patient outcomes.
Chitogel remains in the sinus cavity during the critical healing period to enhance wound healing, support a healthy microbiome, and preserve ostial patency. Chitogel also enhances patient comfort, minimizes scarring, and controls minimal bleeding.
Chitogel is backed by extensive research, published studies, and successful patient outcomes. It is expertly formulated to meet the critical success criteria of ESS.
Clinically Proven Results
- Improved Ostial Patency: Chitogel significantly enhances ostial patency, especially in the frontal sinus, with a 73% improvement in frontal ostial area and substantial improvements in other areas.
- Reduced Adhesion Formation: Chitogel results in a 47% reduction in adhesions compared to using no packing materials.
- Patient Comfort and Compliance: Chitogel is a soft, pliable, and comfortable gel that is easy on patients after surgery and clears naturally with standard nasal irrigation.
How does Chitogel Achieve This?
Chitogel’s unique benefits are attributed to the combination of three natural ingredients: Chitosan Succinamide, Dextran Aldehyde, and Glycerol. Learn more about how these ingredients work to improve patient outcomes on our home page: https://www.chitogel.com/nz/
Enhancing Post-Operative Care and the Patient Experience
Endoscopic Sinus Surgeons worldwide are increasingly choosing Chitogel over traditional packing methods, and patients report faster healing processes with complication-free outcomes.
Chitogel is continuing to enhance post-operative care for sinusitis patients and improve ESS outcomes, ensuring a smoother recovery.
